Atossa Genetics Inc. (Nasdaq:ATOS) announced that it has received a request for additional information from the U.S. Food and Drug Administration (FDA) related to its 510(k) application for the ForeCYTE Breast Aspirator. Atossa plans to request an extension to the 30 day time limit by which a response must be provided to the FDA. If the request for an extension is granted, Atossa will have up to 180 days to provide a response to the FDA’s questions.Atossa Genetics Inc (NASDAQ:ATOS) stock opened at $1.86 in last session, and closed at $1.81, while the day range of stock is $1.80 – $1.86. The stock showed a negative weekly performance of -17.73%.
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced the appointment of Edward Jordan as Senior Vice President of sales and marketing. William Heiden, President and CEO of AMAG, commented, “I have known Ed for many years, and am confident that, with his deep experience in pharmaceutical and device commercial leadership, he will be a great addition to our executive team. AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) stock opened at $22.06, in last session and closed at $22.42, by gaining 2.47%. The 52 week range of the stock is $18.46 – $28.42. Company’s market capitalization is $488.76 million.
Oxford Immunotec Global PLC (NASDAQ:OXFD) was upgraded by analysts at EVA Dimensions from a “sell” rating to an “underweight” rating in a research report issued to clients and investors on Wednesday, AnalystRatings.NET reports.Oxford Immunotec Global PLC (NASDAQ:OXFD) stock advanced 2.82% and finished the last session at $24.42. The EPS of the stock remained -0.59. Company’s market capitalization is $420.94 million.
Trade-Ideas LLC identified Idexx Laboratories (NASDAQ:IDXX) as a new lifetime high candidate. IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock opened the session at $127.06, and closed the session at $126.73. The 52 week range of the stock remained $81.57 – $127.45 and the day range was $126.00 – $127.38.
Leave a Reply